Kelyniam Global, Inc. (KLYG)
USD 0.22
(22.22%)
USD 0.22
(22.22%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.27 Million USD | 1.1% |
| 2022 | 2.25 Million USD | 22.8% |
| 2021 | 1.83 Million USD | 67.82% |
| 2020 | 1.09 Million USD | -7.23% |
| 2019 | 1.17 Million USD | 1.15% |
| 2018 | 1.16 Million USD | 18.34% |
| 2017 | 983.3 Thousand USD | 22.23% |
| 2016 | 804.46 Thousand USD | -4.05% |
| 2015 | 838.45 Thousand USD | -7.22% |
| 2014 | 903.66 Thousand USD | 2.9% |
| 2013 | 878.23 Thousand USD | 0.0% |
| 2007 | 219.64 Thousand USD | 48.05% |
| 2006 | 148.35 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 601.25 Thousand USD | -3.71% |
| 2024 Q2 | 526.7 Thousand USD | -12.4% |
| 2023 Q1 | 573.67 Thousand USD | -12.42% |
| 2023 FY | 2.27 Million USD | 1.13% |
| 2023 Q2 | 545.72 Thousand USD | -4.87% |
| 2023 Q3 | 522.84 Thousand USD | -4.19% |
| 2023 Q4 | 624.45 Thousand USD | 19.43% |
| 2022 Q4 | 655.02 Thousand USD | 35.89% |
| 2022 Q2 | 612.98 Thousand USD | 21.45% |
| 2022 Q1 | 504.73 Thousand USD | -0.8% |
| 2022 FY | 2.25 Million USD | 22.8% |
| 2022 Q3 | 482.02 Thousand USD | -21.36% |
| 2021 FY | 1.83 Million USD | 67.82% |
| 2021 Q2 | 390.91 Thousand USD | -19.13% |
| 2021 Q3 | 449.39 Thousand USD | 14.96% |
| 2021 Q1 | 483.39 Thousand USD | 151.88% |
| 2021 Q4 | 508.83 Thousand USD | 13.23% |
| 2020 Q1 | 235.99 Thousand USD | -49.15% |
| 2020 Q4 | 191.91 Thousand USD | -28.57% |
| 2020 FY | 1.09 Million USD | -7.23% |
| 2020 Q3 | 268.66 Thousand USD | -3.43% |
| 2020 Q2 | 278.19 Thousand USD | 17.89% |
| 2019 Q2 | 323 Thousand USD | 7.09% |
| 2019 FY | 1.17 Million USD | 1.15% |
| 2019 Q4 | 464.05 Thousand USD | 29.24% |
| 2019 Q1 | 301.63 Thousand USD | 0.0% |
| 2019 Q3 | 359.06 Thousand USD | 11.16% |
| 2018 FY | 1.16 Million USD | 18.34% |
| 2017 FY | 983.3 Thousand USD | 22.23% |
| 2016 FY | 804.46 Thousand USD | -4.05% |
| 2015 FY | 838.45 Thousand USD | -7.22% |
| 2014 Q1 | 218.72 Thousand USD | 0.0% |
| 2014 FY | 903.66 Thousand USD | 2.9% |
| 2014 Q3 | 210.42 Thousand USD | 0.0% |
| 2014 Q4 | 256.52 Thousand USD | 21.91% |
| 2013 Q2 | 226.81 Thousand USD | -7.91% |
| 2013 Q1 | 246.3 Thousand USD | 0.0% |
| 2013 FY | 878.23 Thousand USD | 0.0% |
| 2008 Q1 | 63.4 Thousand USD | -72.15% |
| 2007 Q1 | 19.23 Thousand USD | 0.0% |
| 2007 Q4 | 227.63 Thousand USD | 1408.88% |
| 2007 Q3 | 15.08 Thousand USD | 132.49% |
| 2007 FY | 219.64 Thousand USD | 48.05% |
| 2007 Q2 | -46.42 Thousand USD | -341.35% |
| 2006 FY | 148.35 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | -207.185% |
| IR-Med Inc. | 4.89 Million USD | 53.51% |
| Polarean Imaging plc | 12.24 Million USD | 81.415% |
| Medical Supply International USA, Inc. | 1.32 Million USD | -72.302% |
| Avitar, Inc. | 3.56 Million USD | 36.259% |
| AVITA Medical, Inc. | 80.77 Million USD | 97.183% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -223.648% |
| Össur hf. | 396.18 Million USD | 99.426% |
| Zecotek Photonics Inc. | 3.46 Million USD | 34.269% |
| QHSLab, Inc. | 961.65 Thousand USD | -136.597% |
| Wellstar International, Inc. | 1.79 Million USD | -26.776% |
| Össur hf. | 396.18 Million USD | 99.426% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 89.553% |
| Escalon Medical Corp. | 5.25 Million USD | 56.668% |
| Aurora Spine Corporation | 8.65 Million USD | 73.719% |
| BrainsWay Ltd. | 28.01 Million USD | 91.879% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 9.56 Million USD | 76.211% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 93.223% |
| Vivos Inc. | 2.78 Million USD | 18.365% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.783% |
| REMSleep Holdings, Inc. | 1.01 Million USD | -124.183% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -422.444% |
| Nanomix Corporation | 8.36 Million USD | 72.809% |
| Theraclion SA | 7.43 Million USD | 69.418% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | -75.752% |
| Positron Corporation | 1 Million USD | -125.879% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | 26.852% |
| Lombard Medical, Inc. | 30.29 Million USD | 92.488% |
| ALR Technologies Inc. | 6.33 Million USD | 64.09% |
| Stratec SE | 46.32 Million USD | 95.088% |
| Vycor Medical, Inc. | 1.27 Million USD | -78.386% |
| Heart Tronics, Inc. | 14.46 Million USD | 84.265% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -1787.762% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -1002.245% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 83.922% |
| VMS Rehab Systems, Inc. | 63.63 USD | -3575641.003% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 34.863% |
| Ingen Technologies, Inc. | 1.88 Million USD | -20.881% |
| Odyssey Group International, Inc. | -14.26 Million USD | 115.954% |
| United American Healthcare Corporation | 59 Thousand USD | -3756.346% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -458.363% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -258.482% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | -34.188% |
| Urologix, Inc. | 10.09 Million USD | 77.455% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -80.099% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 61.75% |
| SS Innovations International, Inc. | 21.38 Million USD | 89.359% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -888.201% |
| Smith & Nephew plc | 3.46 Billion USD | 99.934% |
| NIOX Group Plc | 22.27 Million USD | 89.787% |
| Fuse Medical, Inc. | 10.35 Million USD | 78.017% |
| Broncus Holding Corporation | 38.15 Million USD | 94.036% |
| Brain Scientific Inc. | 9.66 Million USD | 76.453% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 77.917% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -3648.466% |